Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 — Gresham, Oregon

Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 is a clinical research site located in Gresham, Oregon, United States 97030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 has participated in 1 clinical trials.

Therapeutic areas: Meningococcal Infections.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150?

Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 conducted?

Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 has 1 clinical trials on record. Their work covers Meningococcal Infections.

Is Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 accredited by Crixeo Health?

Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 31 - Calcagno Research and Development 24850 SE Stark Street Suite 150?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.